Hideki Garren

Who is Hideki Garren?

Hideki Garren, M.D., Ph.D., EVP, COO, CSO co-founded Bayhill Therapeutics, Inc., in 2001 and is presently its Chief Scientific Officer, Chief Operating Officer, and Executive Vice President. Dr. Garren was also a past member of the adjunct clinical faculty in the Department of Neurology at Stanford University School of Medicine. Dr. Garren received a B.S. from the California Institute of Technology, a Ph.D. in Molecular Biology from the UCLA, Molecular Biology Institute, and an M.D. from the UCLA, School of Medicine. Following medical school Dr. Garren completed neurology residency training as well as a neuroimmunology fellowship at Stanford University. Dr. Garren is an inventor and developer of three DNA vaccines in clinic trials for autoimmune diseases, BHT-3009 for multiple sclerosis, BHT-3021 for type 1 diabetes, and BHT-3034 for myasthenia gravis.